We have made the decision to archive our Twitter/X account. Over the last year, we have seen a significant decrease in engagement and reach on the platform and we are shifting our focus to platforms where our audience is more engaged.
This is what you need to know about the science of xenotransplantation, as the field rapidly approaches its first ever clinical trials
https://t.co/0F1joezmLp